Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0002024911-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-09 | 2025-09-06 | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | F - Tax | $295.43 | -413 | 896 | -32% | -$122.0K |
| D | 2025-09-09 | 2025-09-06 | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | M - OptEx | $0.00 | +1,152 | 1,309 | +734% | $0 |
| D | 2025-09-09 | 2025-09-05 | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | A - Grant | $0.00 | +4,110 | 4,110 | New | $0 |
| D | 2025-09-09 | 2025-09-06 | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | M - OptEx | $0.00 | -1,152 | 3,456 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-09-06 | F | D | 413 | $295.43 | 896 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2025-09-06 | M | A | 1,152 | $0.00 | 1,309 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-09-05 | A | A | 4,110 | $0.00 | 4,110 | D | $0.00 · — to — | 4,110 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 4 | Derivative | Restricted Stock Units | 2025-09-06 | M | D | 1,152 | $0.00 | 3,456 | D | $0.00 · — to — | 1,152 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |